News

RTP’s Locus Biosciences grows as it tackles issue of drug-resistant bacteria

RTP’s Locus Biosciences grows as it tackles issue of drug-resistant bacteria

THE NEWS & OBSERVER | Locus Biosciences is expecting more growth in 2022, as the gene-editing company strives to provide alternatives to the pressing issue of drug-resistant bacteria.

 

Full Story